The international liquid biopsy analysis market is experiencing substantial growth, driven by developments in tumor diagnosis and precision healthcare. Current estimates value the market revenue at approximately USD X.X billion dollars in the current year, with expectations pointing to a an predicted CAGR of Y.Z% through 2033. Key trends feature th